October 03, 2018
Rose
Researchers say psilocybin, the active compound in the mushrooms, should be reclassified to treat anxiety and depression. But any such move would be years away.
from Health https://ift.tt/2QwqrfB
October 03, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
A National Medical License May Ease Canada’s Doctor Shortages- How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
- Preterm Birth Drug Withdrawn After 12 Years
- Jiang Yanyong, Who Helped Expose China’s SARS Crisis, Dies at 91
- Heartbeat May Shape Our Perception of Time, Study Shows
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment